COIOSDeep risk insights through multi-disciplinary research across the globe
African American man at a cash register in a Sears department store
Item refines Peer-reviewed Added

Slow restart of blood pressure drugs carried higher cardiovascular risk in SPRINT

In the SPRINT trial, participants whose blood pressure drugs were reduced and not promptly restored under the standard target had a 34% higher rate of major cardiovascular events.

The analysis compared SPRINT participants whose blood pressure drugs were reduced before randomisation with those whose treatment was left unchanged. Under the standard target, only 52.9% were back on their original number of drugs, after a mean of 358 days. Those patients had a 34% higher rate of major cardiovascular events; under the intensive target, restarting was quicker and no excess risk was seen.

Why it is interesting: The reduction in drugs was set by trial protocol rather than chosen by a clinician.

Source
High Blood Pressure & Cardiovascular Prevention, 19 September 2026
Paper
The Impact of Antihypertensive De-escalation: A Secondary Analysis of Systolic Blood Pressure Intervention Trial (SPRINT)
Authors
Du F, Smith SM, Coulombe J, Segal MS, Bress AP, Jiao T
DOI
10.1007/s40292-026-00822-4
Type
Peer-reviewed article
Design
Secondary observational analysis of the SPRINT randomised trial, 8,961 participants across standard (794 vs 3,733) and intensive (427 vs 4,007) arms
Verdict
Refines prior evidence
Driver
Heart and stroke

Other drivers in Health today